Chinese General Practice ›› 2025, Vol. 28 ›› Issue (18): 2205-2211.DOI: 10.12114/j.issn.1007-9572.2024.0540
• Article • Previous Articles Next Articles
Received:
2024-11-11
Revised:
2025-01-14
Published:
2025-06-20
Online:
2025-04-25
Contact:
LIU Tao, WANG Yiying
通讯作者:
刘涛, 王艺颖
作者简介:
作者贡献:
梅景雁提出主要研究目标和研究理念,负责研究的构思与设计,撰写论文;陈敏、张列强进行数据的收集与整理,提供统计学方法的设计与思路;潘昀熙、王鑫负责统计学的处理及图表的绘制;赵小登、詹玮进行论文的修订;刘涛、王艺颖对研究进行了思路指导,负责文章的质量控制与审查、整体的监督管理,对文章负责。
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0540
组别 | 例数 | 性别[例(%)] | 年龄(岁) | 居住地区[例(%)] | 婚姻状况[例(%)] | 受教育程度[例(%)] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | 城市 | 乡村 | 未婚 | 已婚/同居 | 小学及以下 | 中学 | 高中及以上 | ||||
非高血压组 | 2 696 | 1 195(44.3) | 1 501(55.7) | 40.9±13.7 | 991(36.8) | 1 705(63.2) | 546(20.3) | 2 150(79.7) | 1 304(48.4) | 891(33.0) | 501(18.6) | |
高血压组 | 852 | 412(48.4) | 440(51.6) | 47.5±14.4 | 288(33.8) | 564(66.2) | 147(17.3) | 705(82.7) | 532(62.4) | 222(26.1) | 98(11.5) | |
检验统计量值 | 4.250 | 12.145a | 2.453 | 3.704 | 54.096 | |||||||
P值 | 0.039 | 0.001 | 0.117 | 0.054 | 0.001 | |||||||
组别 | 体力活动[例(%)] | 吸烟[例(%)] | 饮酒[例(%)] | 高血压家族史[例(%)] | 血脂异常[例(%)] | |||||||
从不 | 多于每周1次 | 否 | 是 | 否 | 是 | 父或母有高血压 | 无 | 情况不明 | 否 | 是 | ||
非高血压组 | 329(12.2) | 2 367(87.8) | 2 157(80.0) | 539(20.0) | 2 642(98.0) | 54(2.0) | 326(12.1) | 1 714(63.6) | 656(24.3) | 1 223(45.4) | 1 473(54.6) | |
高血压组 | 99(11.6) | 753(88.4) | 662(77.7) | 190(22.3) | 830(97.4) | 22(2.6) | 72(8.5) | 541(52.9) | 239(28.1) | 401(47.1) | 451(52.9) | |
检验统计量值 | 0.208 | 2.112 | 1.036 | 11.203 | 0.756 | |||||||
P值 | 0.648 | 0.146 | 0.309 | 0.004 | 0.385 | |||||||
组别 | 油摄入过量[例(%)] | 盐摄入过量[例(%)] | 谷物和淀粉摄入不足[例(%)] | 新鲜蔬菜摄入不足[例(%)] | 新鲜水果摄入不足[例(%)] | 红肉摄入过量[例(%)] | ||||||
否 | 是 | 否 | 是 | 否 | 是 | 否 | 是 | 否 | 是 | 否 | 是 | |
非高血压组 | 793(29.4) | 1 903(70.6) | 836(31.0) | 1 860(69.0) | 2 237(83.0) | 459(17.0) | 1 845(68.4) | 851(31.6) | 225(8.3) | 2 471(91.7) | 2 548(94.5) | 148(5.5) |
高血压组 | 217(25.5) | 635(74.5) | 224(26.3) | 628(73.7) | 699(82.0) | 153(18.0) | 574(67.4) | 278(32.6) | 50(5.9) | 802(94.1) | 811(95.2) | 41(4.8) |
检验统计量值 | 4.947 | 6.878 | 0.394 | 0.338 | 5.556 | 0.589 | ||||||
P值 | 0.026 | 0.009 | 0.530 | 0.561 | 0.018 | 0.443 | ||||||
组别 | 缺乏睡眠[例(%)] | BMI[例(%)] | 收缩压(mmHg) | 舒张压(mmHg) | 空腹血糖(mmol/L) | 累积LAP[M(P25,P75)] | ||||||
否 | 是 | <18.5 kg/m2 | 18.5~23.9 kg/m2 | 24.0~27.9 kg/m2 | ≥28.0 kg/m2 | |||||||
非高血压组 | 2 609(96.8) | 87(3.2) | 166(6.2) | 1 793(66.5) | 608(22.6) | 166(4.7) | 115±12 | 73±8 | 5.21±1.14 | 31.69(19.61,49.69) | ||
高血压组 | 802(94.1) | 50(5.9) | 44(5.2) | 527(61.9) | 220(25.8) | 44(7.1) | 119±12 | 75±8 | 5.27±1.54 | 22.44(13.43,35.71) | ||
检验统计量值 | 12.169 | 13.004 | 0.666a | 4.366a | 5.618a | -11.638b | ||||||
P值 | 0.001 | 0.005 | 0.415 | 0.037 | 0.018 | 0.001 |
Table 1 Baseline data of study subjects
组别 | 例数 | 性别[例(%)] | 年龄(岁) | 居住地区[例(%)] | 婚姻状况[例(%)] | 受教育程度[例(%)] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | 城市 | 乡村 | 未婚 | 已婚/同居 | 小学及以下 | 中学 | 高中及以上 | ||||
非高血压组 | 2 696 | 1 195(44.3) | 1 501(55.7) | 40.9±13.7 | 991(36.8) | 1 705(63.2) | 546(20.3) | 2 150(79.7) | 1 304(48.4) | 891(33.0) | 501(18.6) | |
高血压组 | 852 | 412(48.4) | 440(51.6) | 47.5±14.4 | 288(33.8) | 564(66.2) | 147(17.3) | 705(82.7) | 532(62.4) | 222(26.1) | 98(11.5) | |
检验统计量值 | 4.250 | 12.145a | 2.453 | 3.704 | 54.096 | |||||||
P值 | 0.039 | 0.001 | 0.117 | 0.054 | 0.001 | |||||||
组别 | 体力活动[例(%)] | 吸烟[例(%)] | 饮酒[例(%)] | 高血压家族史[例(%)] | 血脂异常[例(%)] | |||||||
从不 | 多于每周1次 | 否 | 是 | 否 | 是 | 父或母有高血压 | 无 | 情况不明 | 否 | 是 | ||
非高血压组 | 329(12.2) | 2 367(87.8) | 2 157(80.0) | 539(20.0) | 2 642(98.0) | 54(2.0) | 326(12.1) | 1 714(63.6) | 656(24.3) | 1 223(45.4) | 1 473(54.6) | |
高血压组 | 99(11.6) | 753(88.4) | 662(77.7) | 190(22.3) | 830(97.4) | 22(2.6) | 72(8.5) | 541(52.9) | 239(28.1) | 401(47.1) | 451(52.9) | |
检验统计量值 | 0.208 | 2.112 | 1.036 | 11.203 | 0.756 | |||||||
P值 | 0.648 | 0.146 | 0.309 | 0.004 | 0.385 | |||||||
组别 | 油摄入过量[例(%)] | 盐摄入过量[例(%)] | 谷物和淀粉摄入不足[例(%)] | 新鲜蔬菜摄入不足[例(%)] | 新鲜水果摄入不足[例(%)] | 红肉摄入过量[例(%)] | ||||||
否 | 是 | 否 | 是 | 否 | 是 | 否 | 是 | 否 | 是 | 否 | 是 | |
非高血压组 | 793(29.4) | 1 903(70.6) | 836(31.0) | 1 860(69.0) | 2 237(83.0) | 459(17.0) | 1 845(68.4) | 851(31.6) | 225(8.3) | 2 471(91.7) | 2 548(94.5) | 148(5.5) |
高血压组 | 217(25.5) | 635(74.5) | 224(26.3) | 628(73.7) | 699(82.0) | 153(18.0) | 574(67.4) | 278(32.6) | 50(5.9) | 802(94.1) | 811(95.2) | 41(4.8) |
检验统计量值 | 4.947 | 6.878 | 0.394 | 0.338 | 5.556 | 0.589 | ||||||
P值 | 0.026 | 0.009 | 0.530 | 0.561 | 0.018 | 0.443 | ||||||
组别 | 缺乏睡眠[例(%)] | BMI[例(%)] | 收缩压(mmHg) | 舒张压(mmHg) | 空腹血糖(mmol/L) | 累积LAP[M(P25,P75)] | ||||||
否 | 是 | <18.5 kg/m2 | 18.5~23.9 kg/m2 | 24.0~27.9 kg/m2 | ≥28.0 kg/m2 | |||||||
非高血压组 | 2 609(96.8) | 87(3.2) | 166(6.2) | 1 793(66.5) | 608(22.6) | 166(4.7) | 115±12 | 73±8 | 5.21±1.14 | 31.69(19.61,49.69) | ||
高血压组 | 802(94.1) | 50(5.9) | 44(5.2) | 527(61.9) | 220(25.8) | 44(7.1) | 119±12 | 75±8 | 5.27±1.54 | 22.44(13.43,35.71) | ||
检验统计量值 | 12.169 | 13.004 | 0.666a | 4.366a | 5.618a | -11.638b | ||||||
P值 | 0.001 | 0.005 | 0.415 | 0.037 | 0.018 | 0.001 |
变量 | 模型1 | 模型2 | 模型3 | |||
---|---|---|---|---|---|---|
aHR(95%CI) | P值 | aHR(95%CI) | P值 | aHR(95%CI) | P值 | |
Q1组 | 1 | 1 | 1 | |||
Q2组 | 1.313(1.041~1.655) | 0.022 | 1.337(1.058~1.690) | 0.015 | 1.330(1.053~1.681) | 0.017 |
Q3组 | 1.754(1.411~2.181) | <0.01 | 1.747(1.397~2.184) | <0.01 | 1.706(1.364~2.134) | <0.01 |
Q4组 | 2.388(1.939~2.940) | <0.01 | 2.373(1.896~2.969) | <0.01 | 2.339(1.869~2.928) | <0.01 |
Table 2 Results of the Cox proportional regression model for the relationship between cumulative LAP and new-onset hypertension
变量 | 模型1 | 模型2 | 模型3 | |||
---|---|---|---|---|---|---|
aHR(95%CI) | P值 | aHR(95%CI) | P值 | aHR(95%CI) | P值 | |
Q1组 | 1 | 1 | 1 | |||
Q2组 | 1.313(1.041~1.655) | 0.022 | 1.337(1.058~1.690) | 0.015 | 1.330(1.053~1.681) | 0.017 |
Q3组 | 1.754(1.411~2.181) | <0.01 | 1.747(1.397~2.184) | <0.01 | 1.706(1.364~2.134) | <0.01 |
Q4组 | 2.388(1.939~2.940) | <0.01 | 2.373(1.896~2.969) | <0.01 | 2.339(1.869~2.928) | <0.01 |
暴露时间 | 最佳截断值 | 灵敏度 | 特异度 | 约登指数 | AUC | 95%CI |
---|---|---|---|---|---|---|
总人群 | ||||||
暴露6年 | 16.470 | 0.469 | 0.278 | 0.191 | 0.617 | 0.578~0.656 |
暴露7年 | 29.295 | 0.454 | 0.286 | 0.167 | 0.590 | 0.546~0.603 |
暴露8年 | 29.295 | 0.453 | 0.271 | 0.182 | 0.603 | 0.550~0.611 |
暴露9年 | 43.345 | 0.634 | 0.397 | 0.237 | 0.634 | 0.553~0.642 |
性别 | ||||||
男性 | ||||||
暴露6年 | 39.090 | 0.412 | 0.245 | 0.167 | 0.600 | 0.543~0.658 |
暴露7年 | 29.190 | 0.372 | 0.247 | 0.125 | 0.561 | 0.509~0.592 |
暴露8年 | 29.295 | 0.390 | 0.242 | 0.147 | 0.571 | 0.512~0.601 |
暴露9年 | 9.183 | 0.430 | 0.307 | 0.123 | 0.558 | 0.483~0.609 |
女性 | ||||||
暴露6年 | 16.839 | 0.670 | 0.426 | 0.243 | 0.638 | 0.689~0.658 |
暴露7年 | 10.255 | 0.532 | 0.324 | 0.208 | 0.629 | 0.642~0.592 |
暴露8年 | 6.845 | 0.642 | 0.414 | 0.228 | 0.647 | 0.652~0.601 |
暴露9年 | 12.775 | 0.825 | 0.476 | 0.349 | 0.711 | 0.708~0.609 |
居住地区 | ||||||
城市 | ||||||
暴露6年 | 58.925 | 0.493 | 0.298 | 0.195 | 0.596 | 0.529~0.663 |
暴露7年 | 75.925 | 0.499 | 0.331 | 0.168 | 0.565 | 0.505~0.611 |
暴露8年 | 64.655 | 0.379 | 0.189 | 0.190 | 0.602 | 0.506~0.635 |
暴露9年 | 112.474 | 0.739 | 0.507 | 0.231 | 0.621 | 0.490~0.654 |
乡村 | ||||||
暴露6年 | 9.468 | 0.649 | 0.438 | 0.211 | 0.629 | 0.581~0.676 |
暴露7年 | 19.408 | 0.424 | 0.274 | 0.15 | 0.592 | 0.542~0.611 |
暴露8年 | 19.408 | 0.422 | 0.264 | 0.157 | 0.594 | 0.540~0.611 |
暴露9年 | 27.305 | 0.627 | 0.395 | 0.232 | 0.635 | 0.556~0.661 |
Table 3 Predictive value of cumulative LAP for new-onset hypertension in different populations
暴露时间 | 最佳截断值 | 灵敏度 | 特异度 | 约登指数 | AUC | 95%CI |
---|---|---|---|---|---|---|
总人群 | ||||||
暴露6年 | 16.470 | 0.469 | 0.278 | 0.191 | 0.617 | 0.578~0.656 |
暴露7年 | 29.295 | 0.454 | 0.286 | 0.167 | 0.590 | 0.546~0.603 |
暴露8年 | 29.295 | 0.453 | 0.271 | 0.182 | 0.603 | 0.550~0.611 |
暴露9年 | 43.345 | 0.634 | 0.397 | 0.237 | 0.634 | 0.553~0.642 |
性别 | ||||||
男性 | ||||||
暴露6年 | 39.090 | 0.412 | 0.245 | 0.167 | 0.600 | 0.543~0.658 |
暴露7年 | 29.190 | 0.372 | 0.247 | 0.125 | 0.561 | 0.509~0.592 |
暴露8年 | 29.295 | 0.390 | 0.242 | 0.147 | 0.571 | 0.512~0.601 |
暴露9年 | 9.183 | 0.430 | 0.307 | 0.123 | 0.558 | 0.483~0.609 |
女性 | ||||||
暴露6年 | 16.839 | 0.670 | 0.426 | 0.243 | 0.638 | 0.689~0.658 |
暴露7年 | 10.255 | 0.532 | 0.324 | 0.208 | 0.629 | 0.642~0.592 |
暴露8年 | 6.845 | 0.642 | 0.414 | 0.228 | 0.647 | 0.652~0.601 |
暴露9年 | 12.775 | 0.825 | 0.476 | 0.349 | 0.711 | 0.708~0.609 |
居住地区 | ||||||
城市 | ||||||
暴露6年 | 58.925 | 0.493 | 0.298 | 0.195 | 0.596 | 0.529~0.663 |
暴露7年 | 75.925 | 0.499 | 0.331 | 0.168 | 0.565 | 0.505~0.611 |
暴露8年 | 64.655 | 0.379 | 0.189 | 0.190 | 0.602 | 0.506~0.635 |
暴露9年 | 112.474 | 0.739 | 0.507 | 0.231 | 0.621 | 0.490~0.654 |
乡村 | ||||||
暴露6年 | 9.468 | 0.649 | 0.438 | 0.211 | 0.629 | 0.581~0.676 |
暴露7年 | 19.408 | 0.424 | 0.274 | 0.15 | 0.592 | 0.542~0.611 |
暴露8年 | 19.408 | 0.422 | 0.264 | 0.157 | 0.594 | 0.540~0.611 |
暴露9年 | 27.305 | 0.627 | 0.395 | 0.232 | 0.635 | 0.556~0.661 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
申元媛. 中国成人脂质蓄积指数与高血压、糖尿病及心血管疾病的关系[D]. 北京:北京协和医学院,2017.
|
[11] |
刘娜. 冠心病患者腹部内脏脂肪与胰岛素抵抗的相关性研究[D]. 石家庄:河北医科大学,2012.
|
[12] |
|
[13] |
|
[14] |
|
[15] |
陈冯梅,郭志荣,海波,等. 体质指数、腰围、腰臀比和腰高比对高血压发病影响前瞻性队列研究[J]. 中国公共卫生,2021,37(12):1774-1777. DOI:10.11847/zgggws1128795.
|
[16] |
|
[17] | |
[18] |
李园,翟凤英,王惠君,等. 中国成年人体质指数和腰围与高血压关系的四年随访研究[J]. 卫生研究,2007,36(4):478-480. DOI:10.3969/j.issn.1000-8020.2007.04.020.
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[1] | WANG Zhijun, ZHANG Shibo, LIU Jie, LI Dongqi, ZHENG Meijia, ZHOU Jianzhi. Correlation Analysis between TyG-BMI Index and Nocturnal Hypertension in Patients with Hypertension [J]. Chinese General Practice, 2025, 28(18): 2212-2221. |
[2] | ZHANG Zhidong, JIN Hua, HU Jihong, JIANG Lu, WANG Li, LONG Kaichong, ZHANG Ronghua. Analysis and Prediction of the Incidence and Mortality Trends of Hypertensive Nephropathy in China from 1990 to 2021 [J]. Chinese General Practice, 2025, 28(18): 2262-2269. |
[3] | HE Yan, CUI Saixian, HU Yang, NI Qing, GAN Lulu, LIU Qian, DAI Anni, LIU Shijie, YANG Li. Influencing Factors on Urinary Sodium Excretion in Patients with Obstructive Sleep Apnea-Associated Hypertension [J]. Chinese General Practice, 2025, 28(18): 2222-2227. |
[4] | LYU Lulu, ZHU Wanjie, XIAO Mingyang, LI Yike, ZHANG Juan. Correlation Analysis of the Circadian Rhythmicity of Blood Pressure with Ox-LDL/β2GPI Complex and Carotid Atherosclerosis in Patients with Essential Hypertension [J]. Chinese General Practice, 2025, 28(18): 2228-2233. |
[5] | WANG Biqing, ZHANG Ping, YANG Hongxia, WANG Qian, JU Chunxiao, ZHAO Junnan, MEI Jun, ZHANG Ying, XU Fengqin. Meta-analysis of Prevalence and Development Trend of Mild Cognitive Impairment in Elderly Hypertensive Patients in China [J]. Chinese General Practice, 2025, 28(17): 2186-2192. |
[6] | HE Ting, LI Jia, TAN Wenbin. Research Progress of Circulatory System Diseases and Secondary Osteoporosis [J]. Chinese General Practice, 2025, 28(17): 2101-2112. |
[7] | HUANG Zhijie, MAI Zhihua, WANG Haoxiang, HE Yuming, DENG Qiaoyan, DAI Ranran, ZHOU Zhiheng. Multimorbidity of Hypertension, Diabetes, and Dyslipidemia and Influencing Factors of Family Function among the Elderly [J]. Chinese General Practice, 2025, 28(16): 2001-2010. |
[8] | AN Qinyu, WANG Yiying, ZHANG Xiaodan, ZHANG Tianlin, ZHAN Qingqing, ZHANG Fuyan, LIU Tao, WU Yanli. Prospective Cohort Study of the Impact of Socioeconomic Status and Healthy Lifestyle on Cardiovascular Disease [J]. Chinese General Practice, 2025, 28(16): 2017-2024. |
[9] | CAO Chenchen, ZHENG Lyuyun, WANG Lin, LIU Jing. Preference Study on Family Doctor Contract Service among Patients with Hypertension and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(16): 2011-2016. |
[10] | CHEN Dian, LONG Huanyu, ZHANG Congxi, CHU Lanhe, LI Shurun, CHEN Yahong. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2025 Report [J]. Chinese General Practice, 2025, 28(16): 1937-1949. |
[11] | ZHANG Xin, ZHU Qing, LI Nanfang. Association of Lipid Accumulation Product Index and Chronic Kidney Disease in Patients with Hypertension with Abnormal Glucose Metabolism: a Retrospective Cohort Study [J]. Chinese General Practice, 2025, 28(15): 1840-1846. |
[12] | SUI Hongping, LI Tingting, JIANG Tongtong, XIA Yunlong, SHI Tieying. Research Progress on Blood Pressure Management of Vascular Endothelial Growth Factor Signaling Pathway Inhibitor-related Hypertension [J]. Chinese General Practice, 2025, 28(15): 1932-1936. |
[13] | SUN Qinyu, DENG Yifan, HE Shenghu, ZHANG Jing. Study of the Predictive Value of Neutrophil/Lymphocyte Ratio, Monocyte/High-density Lipoprotein Cholesterol Ratio, and the Combination of the Two for Contrast Nephropathy after Emergency PCI in Patients with Acute ST-segment Elevation Myocardial Infarction [J]. Chinese General Practice, 2025, 28(15): 1891-1897. |
[14] | ZHANG Ning, FAN Shiming, REN Ming, SHEN Youlu, MA Yanmei, DOU Xiaohong, PU Cuo, LU Xingqin, HUANG Qiang, XUE Rui, WANG Fuyan, LIN Ying, ZHANG Jihui, TIAN Huizhen, HAN Ping, HAN Yujuan, HAN Shuping, LIU Qingling, LU Tianlong, LU Yongliang, E Weijian. Study on the Relationship between Homocysteine Levels, Polymorphisms of Homocysteine Metabolizing Enzyme Genes, Blood Pressure, and Oxidative Stress Levels in Hypertensive Patients at Different Altitudes [J]. Chinese General Practice, 2025, 28(15): 1862-1870. |
[15] | ZHANG Shujing, SUN Lixin, CAO Yuqing. Comparative Study on the Clinicopathological Features and Prognostic between HPV-related and Non-HPV-related Cervical Adenocarcinoma [J]. Chinese General Practice, 2025, 28(14): 1758-1764. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||